GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men
- Conditions
- HIV/AIDSSexually Transmitted InfectionHealth Behavior
- Interventions
- Behavioral: GPS program
- Registration Number
- NCT03186183
- Lead Sponsor
- Toronto Metropolitan University
- Brief Summary
GPS is a sexual health promotion and HIV prevention peer-delivered counselling program. The GPS program has 4 parts: information provision about HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care. The adaptation grant has three goals: 1) to establish a multi-region and multi-sectoral team that can deliver the revised program across a variety of settings, 2) to learn how best to deliver this program as individual counselling program and also how to adapt this program for HIV-negative MSM, and 3) to pilot the individual program in 5 settings across Ontario and British Columbia. The research team will evaluate the pilot adaptation through mixed methods, employing a quantitative questionnaire and one-on-one semi-structured interviews.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 50
- aged 18 years or older
- self-identify as a man
- self-identify as gay, bisexual, queer, same-gender-loving, or a man who has sex with men
- report having engaged in condomless anal sex in the last 3 months
- able to speak, read, and aurally comprehend English
- depending on the study site, report HIV-negative or HIV-positive status
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description GPS program GPS program The individual GPS motivational interviewing counseling program has 4-6 sessions. Week 1: information on sexually transmitted infections and HIV disclosure laws is reviewed. Participants are introduced to the sex diary, stress exercise, and stages of change model. Week 2: a decisional balance exercise about the participant's current sexual behavior is completed and a behavioral goal is chosen. Week 3: participants explore their greatest fears and hopes about the goal, and the importance of and their confidence in achieving it. Week 4: the facilitator and participant identify triggers, automatic thoughts, counters, strategies, supports, and rewards pertaining to the pursuit of the goal and role play the new goal. 1-2 supplemental sessions may be added as needed.
- Primary Outcome Measures
Name Time Method Change in the number of serodiscordant condomless anal sex acts Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) Participants will be asked to report the number of times they engaged in anal sex in the without a condom with a partner of opposite or unknown HIV status in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
- Secondary Outcome Measures
Name Time Method Change in the number of sexual partners Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) Participants will be asked to report the number of sexual partners they had who are HIV-positive, HIV-negative, and of unknown HIV status in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Change in HIV viral load status Most recent viral load test (asked at baseline, post-treatment, and 3-month follow-up) HIV-positive participants will be asked to report whether they had a detectable or undetectable HIV viral load at their last viral load test as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Change in the number of receptive condomless anal sex acts Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) Participants will be asked to report the number of times they engaged in receptive anal sex without a condom in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Change in the number of insertive condomless anal sex acts Past 2 months (measured at baseline, post-treatment, and 3-month follow-up) Participants will be asked to report the number of times they engaged in insertive anal sex without a condom in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Change in use of HIV pre-exposure prophylaxis (PrEP) Present use (asked at baseline, post-treatment, and 3-month follow-up) For HIV-negative participants, participants will be asked whether they use HIV PrEP as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Trial Locations
- Locations (6)
Regional HIV/AIDS Connection
🇨🇦London, Ontario, Canada
Immunodeficiency Clinic - The Ottawa Hospital
🇨🇦Ottawa, Ontario, Canada
Gay ZONE (Centretown Community Health Centre)
🇨🇦Ottawa, Ontario, Canada
Health Initiative for Men
🇨🇦Vancouver, British Columbia, Canada
MAX Ottawa
🇨🇦Ottawa, Ontario, Canada
AIDS Committee of Toronto
🇨🇦Toronto, Ontario, Canada